Literature DB >> 19497299

Pore-forming toxins activate MAPK p38 by causing loss of cellular potassium.

Nicole Kloft1, Tim Busch, Claudia Neukirch, Silvia Weis, Fatima Boukhallouk, Wiesia Bobkiewicz, Ingo Cibis, Sucharit Bhakdi, Matthias Husmann.   

Abstract

Mitogen activated protein kinase (MAPK) p38 has emerged as a survival protein in cells that are attacked by bacterial toxins forming small membrane pores. Activation of p38 by pore forming toxins (PFT) has been attributed to osmotic stress, but here we show that loss of K+ is likely to be the critical parameter. Several lines of evidence support this conclusion: first, osmoprotection did not prevent p38-phosphorylation in alpha-toxin-loaded cells. Second, treatment of cells with a K+ ionophore, or simple incubation in K+-free medium sufficed to cause robust p38-phosphorylation. Third, media containing high [K+] prevented p38-activation by Staphylococcus aureus alpha-toxin, Vibrio cholerae cytolysin (VCC), Streptolysin O (SLO), or Escherichia coli hemolysin (HlyA), but did not impair activation by H2O2. Fourth, potential roles of LPS, TLR4, or calcium-influx were ruled out. Therefore, we propose that PFT trigger the p38 MAPK-pathway by causing loss of cellular K+.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19497299     DOI: 10.1016/j.bbrc.2009.05.121

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  44 in total

1.  Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells.

Authors:  Martina Svedova; Jiri Masin; Radovan Fiser; Ondrej Cerny; Jakub Tomala; Marina Freudenberg; Ludmila Tuckova; Marek Kovar; Gilles Dadaglio; Irena Adkins; Peter Sebo
Journal:  Immunol Cell Biol       Date:  2015-10-06       Impact factor: 5.126

Review 2.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 3.  APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease.

Authors:  Pazit Beckerman; Katalin Susztak
Journal:  Trends Mol Med       Date:  2018-06-07       Impact factor: 11.951

Review 4.  Role of MAPK p38 in the cellular responses to pore-forming toxins.

Authors:  Helena Porta; Angeles Cancino-Rodezno; Mario Soberón; Alejandra Bravo
Journal:  Peptides       Date:  2010-06-25       Impact factor: 3.750

5.  Sodium overload and water influx activate the NALP3 inflammasome.

Authors:  Christine Schorn; Benjamin Frey; Kirsten Lauber; Christina Janko; Moritz Strysio; Hildegard Keppeler; Udo S Gaipl; Reinhard E Voll; Eva Springer; Luis E Munoz; Georg Schett; Martin Herrmann
Journal:  J Biol Chem       Date:  2010-11-04       Impact factor: 5.157

Review 6.  The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.

Authors:  Travis J Wiles; Matthew A Mulvey
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

7.  Pro-autophagic signal induction by bacterial pore-forming toxins.

Authors:  Nicole Kloft; Claudia Neukirch; Wiesia Bobkiewicz; Gunnaporn Veerachato; Tim Busch; Gisela von Hoven; Klaus Boller; Matthias Husmann
Journal:  Med Microbiol Immunol       Date:  2010-05-08       Impact factor: 3.402

Review 8.  The Cell Biology of APOL1.

Authors:  John F O'Toole; Leslie A Bruggeman; Sethu Madhavan; John R Sedor
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

9.  A subunit of eukaryotic translation initiation factor 2α-phosphatase (CreP/PPP1R15B) regulates membrane traffic.

Authors:  Nicole Kloft; Claudia Neukirch; Gisela von Hoven; Wiesia Bobkiewicz; Silvia Weis; Klaus Boller; Matthias Husmann
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

10.  Hypoxia and the hypoxic response pathway protect against pore-forming toxins in C. elegans.

Authors:  Audrey Bellier; Chang-Shi Chen; Cheng-Yuan Kao; Hediye N Cinar; Raffi V Aroian
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.